PALISADE BIO, INC. (PALI) Return on equity 2016–2025
PALISADE BIO, INC. (PALI) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-13.0%FY2025 · since FY2016: -186.0% → -13.0%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -13.0% | +179.7 pp |
| FY2024 | -192.7% | -84.0 pp |
| FY2023 | -108.7% | +5.5 pp |
| FY2022 | -114.3% | — |
| FY2018 | -81.4% | +102.6 pp |
| FY2017 | -184.0% | +2.0 pp |
| FY2016 | -186.0% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More PALI financial trends
PALI RevenuePALI Net incomePALI Net marginPALI Gross profitPALI Gross marginPALI Operating incomePALI Operating marginPALI Operating cash flowPALI Free cash flowPALI Capital expendituresPALI Stock buybacksPALI Dividends paidPALI Total assetsPALI Total liabilitiesPALI Shareholders’ equityPALI overview →